国际标准期刊号: 2278-0238

国际药学与生命科学研究与发展杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

The Role of Validations and Quality Management systems Related Regulatory observations in the Global Pharmaceutical sector

Dr. Sagaram Sudhakar

It is very essential to reflect upon the fact that validation activities play a very important and critical role in the Pharmaceutical manufacturing sector. During the project execution the organization should pay a close attention for these activities. And there must be a Risk assessment and risk mitigation program. The Documentation of these activities must be Designed and executed properly. The review of the recent regulatory observations shows that there is a big gap in this regard which leads to the issue of the 483 observations.

Once again it is very interesting to reflect upon the fact that the number. In the GMP warning letters were increased In this presentation we are going to focus on the trends of the warning letters issued in 2018-19 and the trend of the 483 issued by the regulatory authorities.

It is very essential to reflect upon the fact that Documentation activities play a very important and play critical role in the Global Pharmaceutical manufacturing sector. Designee and execution of procedure is possible only thorough Good documentation Practice only During the Regulatory audits the presentation of Documentation roll is very critical and the organization should pay a close attention for these activities. And there must be a Risk assessment and risk mitigation program. The Documentation of these activities must be designed and executed properly.